- Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR).
- Dynamic Assay Range: 0.064 ~ 8 ng/mL.
- Sensitivity: 20 pg/mL
- High Sensitivity Antibody Specific to human LEAP-2 (38-77) Peptide
- LEAP-2 (38-77) Peptide Biotinylated as Tracer
- Positive Control
- Assay Dilution Buffer Ready to Use
- Calibration: the mature human LEAP-2 (38-77) Peptide (disulfide bridges).
- Calibration Range: 0.064 ~ 40 ng/mL.
- Specificity: human and Mouse Bioactive LEAP-2 mature Peptide
- Luminescence Read on top
- Size: 96T, 192T ($880 per 192T) and 480T ($2050 per 480T).
- Extracted Samples for best recovery
- Storage: 12 months
- In-Vitro Research Use Only.
- Protocol of SK00007-06
- Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and cationic antimicrobial peptide that acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR). It regulates energy homeostasis, appetite, and glucose metabolism by inhibiting ghrelin-mediated signaling. LEAP2 levels increase in obesity and decrease in energy-deficit states.
Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and cationic antimicrobial peptide that acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR). It regulates energy homeostasis, appetite, and glucose metabolism by inhibiting ghrelin-mediated signaling. LEAP2 levels increase in obesity and decrease in energy-deficit states.
|